Orthofix Medical Inc. Financial Ratios
OFIX|FY2025 SEC 10-K data
Includes DuPont ROE decomposition, profitability margins, liquidity ratios, solvency indicators, and earnings quality analysis. All ratios calculated from FY2025 SEC 10-K data.
Key Data Points
- Altman Z-Score 1.18 (distress zone, below 1.23 threshold)
- Piotroski F-Score: 2/9 criteria passed
- Currently unprofitable: Net income is negative
- Cash-backed earnings: Operating cash flow exceeds net income
Data sourced from SEC EDGAR filings. Not investment advice.
DuPont ROE Decomposition (FY2025)
Return on Equity
-30.1%
Profit Margin
-20.3%
Net Income / Revenue
Asset Turnover
0.88
Revenue / Total Assets
Equity Multiplier
1.69
Total Assets / Equity
Composite: -30.1% (reported: -30.1%)
Profitability
Liquidity
Current Ratio
2.45
Quick Ratio
1.43
Solvency
Interest Coverage
5.30
Efficiency
Asset Turnover
0.88
Inventory Turnover
1.51
Days Sales Outstanding
66 days
As of FY2025 · SEC 10-K Annual Filings · Updated Jun 28, 2026
Earnings Quality
Accrual Ratio
-12.1%
-11.2pp YoY
Earnings are primarily supported by operating cash flow.
This metric is for informational purposes only and does not constitute investment advice. Data sourced from SEC EDGAR filings; updates may be delayed.